Recent Press Releases

Teva Announces U.S. Supreme Court Will Hear Its Appeal on COPAXONE® Patent

Teva Announces U.S. Supreme Court Will Hear Its Appeal on COPAXONE® Patent JERUSALEM--(BUSINESS WIRE)--Mar. 31, 2014-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced that the...

Pfizer Statement on U.S. FDA Approval of Over-the-Counter Nexium(R) 24HR

Pfizer Statement on U.S. FDA Approval of Over-the-Counter Nexium(R) 24HR NEW YORK--(BUSINESS WIRE)--March 28, 2014-- Today the U.S. Food and Drug Administration (FDA) approved over-the-counter...

GSK announces new strategic investments in Africa to increase access to medicines, build capacity and deliver sustainable growth

GSK announces new strategic investments in Africa to increase access to medicines, build capacity and deliver sustainable growth - Creates world's first R&D Open Lab to increase...

FDA approves Biogen Idec's Alprolix, the first hemophilia B therapy to reduce bleeding episodes with prophylactic infusions starting at least a week apart

FDA approves Biogen Idec's Alprolix, the first hemophilia B therapy to reduce bleeding episodes with prophylactic infusions starting at least a week apart Friday, March 28, 2014 6:24 pm EDT -Only...

GSK announces new strategic investments in Africa to increase access to medicines, build capacity and deliver sustainable growth

GSK announces new strategic investments in Africa to increase access to medicines, build capacity and deliver sustainable growth - Creates world's first R&D Open Lab to increase...

Clinigen Group Acquires Oncology Support Therapy SAVENE® (dexrazoxane) from SpePharm AG

Clinigen Group Acquires Oncology Support Therapy SAVENE® (dexrazoxane) from SpePharm AG Acquisition strengthens Clinigen's position in dexrazoxane market Burton-on-Trent, UK...

Data From Phase 3 Pivotal Studies Show Amgen's Novel Investigational Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Statin Intolerant Patients And In Patients On Statins

Data From Two Separate Phase 3 Studies of Evolocumab (AMG 145), a PCSK9 Inhibitor, Presented in Late-Breaking Clinical Trials Session at ACC.14 - Data Add to the Three Pivotal Studies Presented Ye

GSK acquires full ownership of its Indonesian Consumer Healthcare business

GSK acquires full ownership of its Indonesian Consumer Healthcare business Issued: Friday 28 March 2014, London UK GlaxoSmithKline (GSK) has acquired full ownership of its Indonesian Consumer...

Roche's new time-saving subcutaneous formulation of MabThera approved in Europe for the treatment of common forms of non-Hodgkin Lymphoma

Roche's new time-saving subcutaneous formulation of MabThera approved in Europe for the treatment of common forms of non-Hodgkin Lymphoma MabThera SC offers a faster treatment experience for...

Ventana supports World Health Organization's global classification of haematopoietic and lymphoid cancers

TUCSON, Ariz., March 27, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc.

Spherix Commences Federal Litigation Against Cisco - Sues Cisco for Patent Infringement. Spherix seeks damages and asserts that over $43 billion of Cisco's sales infringe on patents owned by Spherix.

Spherix begins monetization of intellectual property developed by world famous Nortel Networks.

TYSONS CORNER, Va.,

GlaxoSmithKline Recalls alli®

GlaxoSmithKline Recalls alli® MOON TOWNSHIP, Pa., March 27, 2014 MOON TOWNSHIP, Pa., March 27, 2014 /PRNewswire/ -- GlaxoSmithKline (GSK) Consumer Healthcare is voluntarily recalling all...

ABPI comments on NICE's Value Based Assessment consultation

ABPI comments on NICE's Value Based Assessment consultation Commenting on the Value Based Assessment (VBA) consultation launched by the National Institute for Health and Care Excellence (NICE),...

Merck Announces Appointment of Robert M. Davis as Chief Financial Officer; Succeeds Peter N. Kellogg, Who Has Served in the Role Since 2007

Merck Announces Appointment of Robert M. Davis as Chief Financial Officer; Succeeds Peter N. Kellogg, Who Has Served in the Role Since 2007 Thursday, March 27, 2014 7:20 am EDT Dateline: WHITEHOUSE...

In A Subanalysis, The Benefits Of Eliquis® (apixaban) Vs. Warfarin In Reducing The Risk Of Stroke In Patients With Nonvalvular Atrial Fibrillation Were Consistent, Regardless Of Blood Pressure Control 1

In A Subanalysis, The Benefits Of Eliquis® (apixaban) Vs. Warfarin In Reducing The Risk Of Stroke In Patients With Nonvalvular Atrial Fibrillation Were Consistent, Regardless Of Blood Pressure...

Novasep reports full year 2013 results[1] showing strong growth and beating guidance

Novasep reports full year 2013 results[1] showing strong growth and beating guidance Pompey, France, March 27, 2014 - Novasep, a leading supplier of manufacturing solutions to life science...

Baxter Announces Plans to Create Two Separate Leading Global Healthcare Companies

Baxter Announces Plans to Create Two Separate Leading Global Healthcare Companies Independent Companies Will Focus On Biopharmaceuticals And Medical Products Company Plans Tax-Free Distribution Of...

Mylan Wins Breach of Contract Case against GlaxoSmithKline

Mylan Wins Breach of Contract Case against GlaxoSmithKline Jury awards Mylan $106.7 million in damages PITTSBURGH, March 27, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that, after...

SANDOZ RECEIVES APPROVAL FOR BIOSIMILAR FILGRASTIM IN JAPAN

SANDOZ RECEIVES APPROVAL FOR BIOSIMILAR FILGRASTIM IN JAPAN Munich, Germany, March 24, 2014 Sandoz Filgrastim approved in all indications as the reference product Sandoz becomes first company to...

Amgen To Webcast Investor Meeting At Upcoming American College of Cardiology's 63rd Annual Scientific Session

THOUSAND OAKS, Calif., March 26, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcast investor meetin